Pharma Majors Bounce Back
NEW DELHI, AUG 2: Indian pharma majors,
except Ranbaxy Laboratories Ltd, have bounced back with
double digit profit growth in the quarter ending June
as a result of improved performance across geographies.
While Dr Reddy's saw net profits double, Sun, Cipla
and Wockhardt's net improved 67%, 41% and 55% respectively.
In the January-March quarter, all these companies, except
Cipla, saw declining profits or losses due to various
issues like value-added tax and MRP-based excise.
August 03, 2005